Ubs Asset Management Americas Inc Uro Gen Pharma Ltd. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 4,360,524 shares of URGN stock, worth $34.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,360,524
Previous 1,377,156
216.63%
Holding current value
$34.9 Million
Previous $14.7 Million
228.84%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Rtw Investments, LP New York, NY3.83MShares$30.7 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$25.7 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$18.4 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$17.6 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$17.2 Million1.7% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $182M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...